{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:07:26Z","timestamp":1788307646864,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p><jats:italic>Clostridium perfringens<\/jats:italic>is the causative agent of several diseases and enteric infections in animals and humans. The virulence of<jats:italic>C. perfringens<\/jats:italic>is largely attributable to the production of numerous toxins; of these, the alpha toxin (CPA) plays a crucial role in histotoxic infections (gas gangrene). CPA toxin consists of two domains, i.e., the phospholipase C active site, which lies in the N-terminal domain amino acid (aa residues 1\u2013250), and the C-terminal region (aa residues 251\u2013370), which is responsible for the interaction of the toxin with membrane phospholipids in the presence of calcium ions. All currently produced clostridial vaccines contain toxoids derived from culture supernatants that are inactivated, mostly using formalin. The CPA is an immunogenic antigen; recently, it has been shown that mice that were immunized with the C-terminal domain of the toxin produced in<jats:italic>E. coli<\/jats:italic>were protected against<jats:italic>C. perfringens<\/jats:italic>infections and the anti-sera produced were able to inhibit the CPA activity. Monoclonal and polyclonal antibodies were produced only against full-length CPA and not against the truncated forms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the present study, we have reported for the first time; about the generation of a recombinant baculovirus capable of producing a deleted rCPA toxin (rBacCPA250\u2013363H6) lacking the N-terminal domain and the 28 amino acids (aa) of the putative signal sequence. The insertion of the<jats:italic>L21<\/jats:italic>consensus sequence upstream of the translational start codon ATG, drastically increases the yield of recombinant protein in the baculovirus-based expression system. The protein was purified by Ni-NTA affinity chromatography and the lack of toxicity in vitro was confirmed in CaCo-2 cells. Polyclonal antibodies and eight hybridoma-secreting Monoclonal antibodies were generated and tested to assess specificity and reactivity. The anti-sera obtained against the fragment rBacCPA250\u2013363H6 neutralized the phospholipase C activity of full-length PLC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The<jats:italic>L21<\/jats:italic>leader sequence enhanced the expression of atoxic C-terminal recombinant CPA protein produced in insect cells. The monoclonal and polyclonal antibodies obtained were specific and highly reactive. The availability of these biologicals could contribute to the development of diagnostic assays and\/or new recombinant protein vaccines.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12896-019-0597-4","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T09:03:41Z","timestamp":1580202221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Generation of recombinant baculovirus expressing atoxic C-terminal CPA toxin of Clostridium perfringens and production of specific antibodies"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0405-2938","authenticated-orcid":false,"given":"Katia","family":"Forti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Cagiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Anzalone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Di Paolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Corneli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Severi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"De Giuseppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,28]]},"reference":[{"key":"597_CR1","doi-asserted-by":"crossref","unstructured":"Rood JI, Adams V, Lacey J, Lyras D, BA MC, Melville SB, et al. Expansion of the Clostridium perfringens toxin-based typing scheme. Anaerobe. 2018.","DOI":"10.1016\/j.anaerobe.2018.04.011"},{"key":"597_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/3527600108.ch6","volume-title":"Clostridia: Biotecnology and Medical Application","author":"BA McClane","year":"2005","unstructured":"McClane BA, Rood JI. Clostridial Toxins Involved in Human Enteric and Histotoxic Infections. In: Clostridia: Biotecnology and Medical Application; 2005. p. 169\u2013209."},{"issue":"3","key":"597_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2217\/fmb.13.168","volume":"9","author":"FA Uzal","year":"2014","unstructured":"Uzal FA, Freedman JC, Shrestha A, Theoret JR, Garcia J, Awad MM, et al. Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. Future Microbiol. 2014;9(3):361\u201377.","journal-title":"Future Microbiol"},{"issue":"8","key":"597_CR4","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.toxicon.2003.11.013","volume":"42","author":"Marietta Flores-D\u0131\u0301az","year":"2003","unstructured":"Flores-D\u0131\u0301az M, Alape-Gir\u00f3n A. Role of Clostridium perfringens phospholipase C in the pathogenesis of gas gangrene. Toxicon 2003;42(8):979\u2013986.","journal-title":"Toxicon"},{"issue":"12","key":"597_CR5","doi-asserted-by":"publisher","first-page":"7904","DOI":"10.1128\/IAI.69.12.7904-7910.2001","volume":"69","author":"MM Awad","year":"2001","unstructured":"Awad MM, Ellemor DM, Boyd RL, Emmins JJ, Rood JI. Synergistic effects of alpha-toxin and Perfringolysin O in Clostridium perfringens-mediated gas gangrene. Infect Immun. 2001;69(12):7904\u201310.","journal-title":"Infect Immun"},{"issue":"2","key":"597_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/1875414701003020024","volume":"3","author":"FA Uzal","year":"2010","unstructured":"Uzal FA, Vidal JE, McClane BA, Gurjar AA. Clostridium Perfringens toxins involved in mammalian veterinary diseases~!2009-08-24~!2009-09-11~!2010-03-09~! Open Toxinology J. 2010;3(2):24\u201342.","journal-title":"Open Toxinology J"},{"issue":"5","key":"597_CR7","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/j.1365-2958.1994.tb01063.x","volume":"12","author":"M Lyristis","year":"1994","unstructured":"Lyristis M, Bryant AE, Sloan J, Awad MM, Stevens NIT, D.L. RJI. Identification and molecular analysis of a locus that regulates extracellular toxin production in Clostridium perfringens. Mol Microbiol. 1994;12(5):761\u201377.","journal-title":"Mol Microbiol"},{"issue":"4","key":"597_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.resmic.2014.09.010","volume":"166","author":"K Ohtani","year":"2015","unstructured":"Ohtani K, Shimizu T. Regulation of toxin gene expression in Clostridium perfringens. Res Microbiol. 2015;166(4):280\u20139.","journal-title":"Res Microbiol"},{"issue":"5","key":"597_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jbiosc.2017.12.019","volume":"125","author":"K Adachi","year":"2018","unstructured":"Adachi K, Ohtani K, Kawano M, Singh RP, Yousuf B, Sonomoto K, et al. Metabolic dependent and independent pH-drop shuts down VirSR quorum sensing in Clostridium perfringens. J Biosci Bioeng. 2018;125(5):525\u201331.","journal-title":"J Biosci Bioeng"},{"key":"597_CR10","unstructured":"Odendaal MW. Purification of the alpha toxin of clostridium perfringens type a me e. Onderstepoon J vet Res. 1987;54:39\u201343."},{"issue":"2","key":"597_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1006\/anae.1999.0191","volume":"5","author":"RW Titball","year":"1999","unstructured":"Titball RW, Naylor CE, Basak AK. The Clostridium perfringens alpha-toxin. Anaerobe. 1999;5(2):51\u201364.","journal-title":"Anaerobe"},{"issue":"3","key":"597_CR12","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1006\/jmbi.1999.3279","volume":"294","author":"CE Naylor","year":"1999","unstructured":"Naylor CE, Jepson M, Crane DT, Titball RW, Miller J, Basak AK, et al. Characterisation of the calcium-binding C-terminal domain of Clostridium perfringens alpha-toxin. J Mol Biol. 1999;294(3):757\u201370.","journal-title":"J Mol Biol"},{"issue":"2","key":"597_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0022-2836(02)00290-5","volume":"319","author":"JT Eaton","year":"2002","unstructured":"Eaton JT, Naylor CE, Howells AM, Moss DS, Titball RW, Basak AK. Crystal structure of the C. perfringens alpha-toxin with the active site closed by a flexible loop region. J Mol Biol. 2002;319(2):275\u201381.","journal-title":"J Mol Biol"},{"issue":"12","key":"597_CR14","doi-asserted-by":"publisher","first-page":"5268","DOI":"10.3390\/toxins7124880","volume":"7","author":"M Oda","year":"2015","unstructured":"Oda M, Terao Y, Sakurai J, Nagahama M. Membrane-binding mechanism of Clostridium perfringens alpha-toxin. Toxins (Basel). 2015;7(12):5268\u201375.","journal-title":"Toxins (Basel)"},{"issue":"5","key":"597_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/toxins10050212","volume":"10","author":"MA Navarro","year":"2018","unstructured":"Navarro MA, McClane BA, Uzal FA. Mechanisms of action and cell death associated with Clostridium perfringens toxins. Toxins (Basel). 2018;10(5):1\u201321.","journal-title":"Toxins (Basel)"},{"issue":"7","key":"597_CR16","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1128\/IAI.67.7.3297-3301.1999","volume":"67","author":"M Jepson","year":"1999","unstructured":"Jepson M, Howells A, Bullifent HL, Bolgiano B, Crane D, Miller J, et al. Differences in the carboxy-terminal (putative phospholipid binding) domains of Clostridium perfringens and Clostridium bifermentans phospholipases C influence the hemolytic and lethal properties of these enzymes. Infect Immun. 1999;67(7):3297\u2013301.","journal-title":"Infect Immun"},{"issue":"12","key":"597_CR17","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/0264-410X(93)90051-X","volume":"11","author":"ED Williamson","year":"1993","unstructured":"Williamson ED, Titball RW. A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene. Vaccine. 1993;11(12):1253\u20138.","journal-title":"Vaccine."},{"key":"597_CR18","doi-asserted-by":"crossref","unstructured":"Nagahama M, Oda M, Kobayashi K, Ochi S, Takagishi T, Shibutani M, et al. A recombinant carboxy-terminal domain of alpha-toxin protects mice against Clostridium perfringens. Microbiol Immunol. 2013.","DOI":"10.1111\/1348-0421.12036"},{"issue":"1","key":"597_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13567-016-0336-y","volume":"47","author":"E Goossens","year":"2016","unstructured":"Goossens E, Verherstraeten S, Valgaeren BR, Pardon B, Timbermont L, Schauvliege S, et al. The C-terminal domain of Clostridium perfringens alpha toxin as a vaccine candidate against bovine necrohemorrhagic enteritis. Vet Res. 2016;47(1):1\u20139.","journal-title":"Vet Res"},{"issue":"4","key":"597_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/cmi.12237","volume":"16","author":"L Monturiol-Gross","year":"2014","unstructured":"Monturiol-Gross L, Flores-D\u00edaz M, Campos-Rodr\u00edguez D, Mora R, Rodr\u00edguez-Vega M, Marks DL, et al. Internalization of Clostridium perfringens ??-toxin leads to ERK activation and is involved on its cytotoxic effect. Cell Microbiol. 2014;16(4):535\u201347.","journal-title":"Cell Microbiol"},{"issue":"1","key":"597_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"T Takagishi","year":"2017","unstructured":"Takagishi T, Takehara M, Seike S, Miyamoto K, Kobayashi K, Nagahama M. Clostridium perfringens \u03b1-toxin impairs erythropoiesis by inhibition of erythroid differentiation. Sci Rep. 2017;7(1):1\u201311.","journal-title":"Sci Rep"},{"issue":"8\u20139","key":"597_CR22","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1042\/bj0350884","volume":"35","author":"MG MacFarlane","year":"1941","unstructured":"MacFarlane MG, Knight BC. The biochemistry of bacterial toxins: the lecithinase activity of cl. Welchii toxins. Biochem J. 1941;35(8\u20139):884\u2013902.","journal-title":"Biochem J"},{"issue":"1\u20132","key":"597_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0014-5793(02)03659-1","volume":"532","author":"K-I Sano","year":"2002","unstructured":"Sano K-I, Maeda K, Oki M, Ma\u00e9da Y. Enhancement of protein expression in insect cells by a lobster tropomyosin cDNA leader sequence. FEBS Lett. 2002;532(1\u20132):143\u20136.","journal-title":"FEBS Lett"},{"issue":"1","key":"597_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12934-017-0707-8","volume":"16","author":"A Serroni","year":"2017","unstructured":"Serroni A, Magistrali CF, Pezzotti G, Bano L, Pellegrini M, Severi G, et al. Expression of deleted, atoxic atypical recombinant beta2 toxin in a baculovirus system and production of polyclonal and monoclonal antibodies. Microb Cell Factories. 2017;16(1):1\u201311.","journal-title":"Microb Cell Factories"},{"issue":"1","key":"597_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1128\/JCM.35.1.228-232.1997","volume":"35","author":"HANS Yoo","year":"1997","unstructured":"Yoo HANS, Lee SUN, Park KY, Park YHO. Molecular typing and epidemiological survey of prevalence of Clostridium perfringens types by multiplex PCR. J Clin Microbiol. 1997;35(1):228\u201332.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"597_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0006-291X(89)91616-1","volume":"160","author":"A Okabe","year":"1989","unstructured":"Okabe A, Shimizu T, Hayashi H. Cloning and sequencing of a phospholipase C gene of Clostridiumperfringens. Biochem Biophys Res Commun. 1989;160(1):33\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"597_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1128\/IAI.57.2.367-376.1989","volume":"57","author":"RW Titball","year":"1989","unstructured":"Titball RW, Hunter SE, Martin KL, Morris BC, Shuttleworth AD, Rubidge T, et al. Molecular cloning and nucleotide sequence of the alpha-toxin (phospholipase C) of Clostridium perfringens. Infect Immun. 1989 Feb;57(2):367\u201376.","journal-title":"Infect Immun"},{"issue":"1","key":"597_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2672.1981.tb00866.x","volume":"50","author":"GJ Rigby","year":"1981","unstructured":"Rigby GJ. An egg-yolk agar diffusion assay for monitoring phospholipase C in cultures of Clostridium welchii. J Appl Bacteriol. 1981;50(1):11\u20139.","journal-title":"J Appl Bacteriol"},{"issue":"1","key":"597_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1746-6148-10-32","volume":"10","author":"E Goossens","year":"2014","unstructured":"Goossens E, Verherstraeten S, Timbermont L, Valgaeren BR, Pardon B, Haesebrouck F, et al. Clostridium perfringens strains from bovine enterotoxemia cases are not superior in in vitro production of alpha toxin, perfringolysin O and proteolytic enzymes. BMC Vet Res. 2014;10(1):1\u20137.","journal-title":"BMC Vet Res"},{"issue":"8","key":"597_CR30","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.tiv.2012.03.009","volume":"26","author":"M Natoli","year":"2012","unstructured":"Natoli M, Leoni BD, D\u2019Agnano I, Zucco F, Felsani A. Good Caco-2 cell culture practices. Toxicol In Vitro. 2012;26(8):1243\u20136.","journal-title":"Toxicol In Vitro"},{"issue":"4","key":"597_CR31","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.jmb.2003.07.016","volume":"333","author":"GC Clark","year":"2003","unstructured":"Clark GC, Briggs DC, Karasawa T, Wang X, Cole AR, Maegawa T, et al. Clostridium absonum \u03b1-toxin: new insights into Clostridial phospholipase C substrate binding and specificity. J Mol Biol. 2003;333(4):759\u201369.","journal-title":"J Mol Biol"},{"issue":"4","key":"597_CR32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.micpath.2007.05.004","volume":"43","author":"BN Neeson","year":"2007","unstructured":"Neeson BN, Clark GC, Atkins HS, Lingard B, Titball RW. Analysis of protection afforded by a Clostridium perfringens \u03b1-toxoid against heterologous clostridial phospholipases C. Microb Pathog. 2007;43(4):161\u20135.","journal-title":"Microb Pathog"},{"key":"597_CR33","doi-asserted-by":"crossref","unstructured":"Zeng J, Song F, Yang Y, Ma C, Deng G, Li Y, et al. The generation and characterization of recombinant protein and antibodies of Clostridium perfringens Beta2 toxin. J Immunol Res. 2016;2016.","DOI":"10.1155\/2016\/5708468"},{"issue":"6","key":"597_CR34","doi-asserted-by":"publisher","first-page":"621","DOI":"10.4315\/0362-028X-59.6.621","volume":"59","author":"ZL Lid","year":"1996","unstructured":"Lid ZL, Blaschek HP. Monoclonal antibody-based ELISA for detection of Clostridium perfringens Alpha-toxin. J Food Prot. 1996;59(6):621\u20135.","journal-title":"J Food Prot"},{"key":"597_CR35","first-page":"726","volume-title":"Antibodies : a laboratory manual. Cold Spring Harbor Laboratory","author":"E Harlow","year":"1988","unstructured":"Harlow E, Lane D. Antibodies : a laboratory manual. Cold Spring Harbor Laboratory; 1988. p. 726."},{"key":"597_CR36","unstructured":"Fabio Malavasi Bargellesi Severi Antonio. Anticorpi monoclonali. Tecniche di base | Fabio Malavasi e Bargellesi Severi Antonio | Forum Service | 1992. Unilibro; 1992. 212 p."},{"issue":"4","key":"597_CR37","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1086\/422691","volume":"190","author":"DL Stevens","year":"2004","unstructured":"Stevens DL, Titball RW, Jepson M, Bayer CR, Hayes-Schroer SM, Bryant AE. Immunization with the C-domain of \u03b1-toxin prevents lethal infection, localizes tissue injury, and promotes host response to challenge with Clostridium perfringens. J Infect Dis. 2004;190(4):767\u201373.","journal-title":"J Infect Dis"},{"issue":"9","key":"597_CR38","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1099\/mic.0.28248-0","volume":"151","author":"RW Titball","year":"2005","unstructured":"Titball RW. Gas gangrene: an open and closed case. Microbiology. 2005;151(9):2821\u20138.","journal-title":"Microbiology"},{"issue":"1","key":"597_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-016-0730-8","volume":"12","author":"E Goossens","year":"2016","unstructured":"Goossens E, Verherstraeten S, Valgaeren BR, Pardon B, Timbermont L, Schauvliege S, et al. Toxin-neutralizing antibodies protect against Clostridium perfringens-induced necrosis in an intestinal loop model for bovine necrohemorrhagic enteritis. BMC Vet Res. 2016;12(1):1\u20138.","journal-title":"BMC Vet Res"},{"issue":"1","key":"597_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.molimm.2015.01.005","volume":"65","author":"D Shreya","year":"2015","unstructured":"Shreya D, Uppalapati SR, Kingston JJ, Sripathy MH, Batra HV. Immunization with recombinant bivalent chimera r-Cpae confers protection against alpha toxin and enterotoxin of Clostridium perfringens type a in murine model. Mol Immunol. 2015;65(1):51\u20137.","journal-title":"Mol Immunol"},{"issue":"1","key":"597_CR41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0167-4781(94)00171-X","volume":"1260","author":"D Hills","year":"1995","unstructured":"Hills D, Crane-Robinson C. Baculovirus expression of human basic fibroblast growth factor from a synthetic gene: role of the Kozak consensus and comparison with bacterial expression. Biochim Biophys Acta. 1995;1260(1):14\u201320.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"597_CR42","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.2174\/138945007782151360","volume":"8","author":"X Shi","year":"2007","unstructured":"Shi X, Jarvis D. Protein N-glycosylation in the Baculovirus-insect cell system. Curr Drug Targets. 2007;8(10):1116\u201325.","journal-title":"Curr Drug Targets"},{"issue":"1","key":"597_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1297-9716-44-45","volume":"44","author":"Stefanie Verherstraeten","year":"2013","unstructured":"Verherstraeten S, Goossens E, Valgaeren B, Pardon B, Timbermont L, Vermeulen K, et al. The synergistic necrohemorrhagic action of Clostridium perfringens perfringolysin and alpha toxin in the bovine intestine and against bovine endothelial cells. Vet Res. 2013;44(1).","journal-title":"Veterinary Research"},{"issue":"1","key":"597_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10565-005-0085-6","volume":"21","author":"Y Sambuy","year":"2005","unstructured":"Sambuy Y, De Angelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F. The Caco-2 cell line as a model of the intestinal barrier: in\u00a3uence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol. 2005;21(1):1\u201326.","journal-title":"Cell Biol Toxicol"},{"issue":"Suppl","key":"597_CR45","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.addr.2012.09.005","volume":"64","author":"P Artursson","year":"2012","unstructured":"Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev. 2012;64(Suppl):280\u20139.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"597_CR46","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1365-2958.1989.tb00183.x","volume":"3","author":"D Leslie","year":"1989","unstructured":"Leslie D, Fairweather N, Pickard D, Dougan G, Kehoe M. Phospholipase C and haemolytic activities of Clostridium perfringens alpha-toxin cloned in Escherichia coli: sequence and homology with a Bacillus cereus phospholipase C. Mol Microbiol. 1989;3(3):383\u201392.","journal-title":"Mol Microbiol"},{"issue":"7","key":"597_CR47","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1021\/bi00407a012","volume":"27","author":"H Moreau","year":"1988","unstructured":"Moreau H, Pieroni G, Jolivet-Reynaud C, Alouf JE, Verger R. A new kinetic approach for studying phospholipase C (Clostridium perfringens .alpha. toxin) activity on phospholipid monolayers. Biochemistry. 1988;27(7):2319\u201323.","journal-title":"Biochemistry"},{"issue":"5","key":"597_CR48","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1046\/j.1365-2958.1997.6161993.x","volume":"26","author":"I Guillouard","year":"1997","unstructured":"Guillouard I, Alzari PM, Saliou B, Cole ST. The carboxy-terminal C2-like domain of the alpha-toxin from Clostridium perfringens mediates calcium-dependent membrane recognition. Mol Microbiol. 1997 Dec;26(5):867\u201376.","journal-title":"Mol Microbiol"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-019-0597-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12896-019-0597-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-019-0597-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T03:27:44Z","timestamp":1665631664000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiotechnol.biomedcentral.com\/articles\/10.1186\/s12896-019-0597-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,28]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["597"],"URL":"https:\/\/doi.org\/10.1186\/s12896-019-0597-4","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,28]]},"assertion":[{"value":"12 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}